SCHEMBL7985494

SCHEMBL7985494

O=c1nc(-c2ccccn2)[nH]c2ncn(Cc3ccccc3)c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 5/20 0.52
PARN O95453 1/20 0.52
PNP P00491 2/20 0.44
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
HIF1A Q16665 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
METAP2 P50579 1/20 0.43
METAP1 P53582 1/20 0.43
PDE4A P27815 1/20 0.42
HPGD P15428 1/20 0.41
BRD4 O60885 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
ADORA2B P29275 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974054 0.91 EGLN1 (0.44) CNOT7PARNALDH1A1SMN1; SMN2NPC1
SCHEMBL7991535 0.91 CNOT7 (0.43) CNOT7PARNALDH1A1SMN1; SMN2NPC1
SCHEMBL7992180 0.90 SMN1; SMN2 (0.45) CNOT7PARNSMN1; SMN2NPC1HTT
SCHEMBL7985291 0.88 CNOT7 (0.54) CNOT7PARNALDH1A1NPC1LMNA
SCHEMBL7991661 0.88 ABCC8 (0.45) CNOT7PARNALDH1A1SMN1; SMN2NPC1
SCHEMBL7974009 0.88 METAP2 (0.41) CNOT7PARNNPC1RAB9AMETAP2
SCHEMBL7991792 0.88 ALDH1A1 (0.44) CNOT7PARNALDH1A1SMN1; SMN2NPC1
SCHEMBL7988804 0.86 CNOT7 (0.55) CNOT7PARNALDH1A1SMN1; SMN2NPC1
SCHEMBL7985461 0.86 TP53 (0.48) NPC1LMNAGAARAB9ARXFP1
SCHEMBL7975271 0.85 CNOT7 (0.56) CNOT7PARNPNPALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed